Jain et al. [47] assert that ETO has repeatedly exhibited chemopreventive and anti-neoplastic properties in the initial phases of colon cancer by promoting the downregulation of the PI3K/Akt oncogenic pathway. This evidence concerns the gene RUNX1T1 and malignant colon neoplasm.